Percutaneous balloon valvuloplasty and coronary angioplasty for the treatment of calcific aortic stenosis and obstructive coronary artery disease in an elderly patient.
An 81-year-old man with severe calcific aortic stenosis and coronary artery disease who refused surgical therapy was treated with sequential percutaneous balloon aortic valvuloplasty (PBAV) and percutaneous transluminal angioplasty. Before percutaneous balloon valvuloplasty, the mean aortic gradient was 76 mmHg, and the aortic valve area was .45 cm2. The aortic valve was dilated using 15-mm and 18-mm balloons. The mean gradient decreased to 40 mmHG, and the aortic valve area increased to .62 cm2. Percutaneous transluminal coronary angioplasty (PTCA) was performed 2 weeks later, and an 85% proximal left circumflex stenosis was successfully dilated to 20%. No complications were noted during either procedure. At 6-month follow-up, the patient had returned to normal activities and was asymptomatic. Thus, combined therapy with PBAV and PTCA is technically feasible in selected elderly patients with calcific aortic stenosis and anatomically suitable coronary artery disease. This nonsurgical therapeutic approach may be useful in the treatment of selected patients who refuse or who are deferred from cardiac surgery.
Vandormael
M
M
Cardiac Catheterization Laboratory, St. Louis University Medical Center, MO 63104.
Deligonul
U
U
Gabliani
G
G
Chaitman
B
B
Kern
M J
MJ
D000368:Aged; D000369:Aged, 80 and over; D000800:Angioplasty, Balloon; D001024:Aortic Valve Stenosis / Q000628:therapy*; D002114:Calcinosis / Q000628:therapy; D002404:Catheterization; D003327:Coronary Disease / Q000628:therapy*; D003331:Coronary Vessels; D006439:Hemodynamics; D006801:Humans; D008297:Male